Publications

COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history.

Townsley, H; Gahir, J; RUSSELL, TW; Greenwood, D; Carr, EJ; Dyke, M; Adams, L; Miah, M; Clayton, B; Smith, C; Miranda, M; Mears, HV; Bailey, C; Black, JR M; Fowler, AS; Crawford, M; Wilkinson, K; Hutchinson, M; Harvey, R; O'Reilly, N; Kelly, G; Goldstone, R; Beale, R; Papineni, P; Corrah, T; ... Wall, EC.

2024

PloS one, (2024).19 3 10.1371/journal.pone.0294897.

Human judgement forecasting of COVID-19 in the UK [version 2; peer review: 2 approved].

BOSSE, NI; ABBOTT, S; Bracher, J; VAN LEEUWEN, E; Cori, A; FUNK, S;

2024

Wellcome open research, (2024).8, 10.12688/wellcomeopenres.19380.2.

Vaccine value profile for Klebsiella pneumoniae.

Dangor, Z; Benson, N; Berkley, JA; Bielicki, J; Bijsma, MW; Broad, J; Buurman, ET; Cross, A; Duffy, EM; HOLT, KE; Iroh Tam, P-Y; JIT, M; Karampatsas, K; Katwere, M; Kwatra, G; Laxminarayan, R; Le Doare, K; Mboizi, R; Micoli, F; Moore, CE; Nakabembe, E; NAYLOR, NR; O'Brien, S; Olwagen, C; Reddy, D; ... Madhi, SA.

2024

Vaccine, (2024).42 19 Sup 10.1016/j.vaccine.2024.02.072.

Towards improving the quality and usefulness of GBD tuberculosis estimates.

WHITE, RG; Rao, JP;

2024

The Lancet. Infectious diseases, (2024).24 7 10.1016/s1473-3099(24)00079-3.

Forecasting the spatial spread of an Ebola epidemic in real-time: comparing predictions of mathematical models and experts.

Munday, J; Rosello, A; EDMUNDS, J; FUNK, S;

2024

medRxiv (2024). 10.1101/2024.03.14.24304285.

Antimicrobial resistance prevalence in bloodstream infection in 29 European countries by age and sex: An observational study.

WATERLOW, NR; Cooper, BS; Robotham, JV; KNIGHT, GM;

2024

PLoS medicine, (2024).21 3 10.1371/journal.pmed.1004301.

Combining models to generate a consensus effective reproduction number<i>R</i>for the COVID-19 epidemic status in England.

Manley, H; Park, J; Bevan, L; Sanchez-Marroquin, A; Danelian, G; Bayley, T; Bowman, V; Maishman, T; Finnie, T; Charlett, A; Watkins, NA; Hutchinson, J; MEDLEY, G; Riley, S; Panovska-Griffiths, J;

2024

Epidemiology and Infection, (2024).152, 10.1017/s0950268824000347.

A global dataset of publicly available dengue case count data.

Clarke, J; LIM, A; Gupte, P; Pigott, DM; Van Panhuis, WG; BRADY, OJ;

2024

Scientific Data, (2024).11 1 10.1038/s41597-024-03120-7.

Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020-30: a modelling study.

Hartner, A-M; Li, X; Echeverria-Londono, S; Roth, J; ABBAS, K; AUZENBERGS, M; De Villiers, MJ; Ferrari, MJ; Fraser, K; FU, H; Hallett, T; Hinsley, W; JIT, M; Karachaliou, A; Moore, SM; Nayagam, S; Papadopoulos, T; Perkins, TA; Portnoy, A; Minh, QT; VYNNYCKY, E; Winter, AK; Burrows, H; CHEN, C; Clapham, HE; ... Gaythorpe, KA M.

2024

The Lancet Global health, (2024).12 4 10.1016/S2214-109X(23)00603-4.

Climate change, thermal anomalies, and the recent progression of dengue in Brazil.

Barcellos, C; Matos, V; Lana, RM; LOWE, R;

2024

Scientific reports, (2024).14 1 10.1038/s41598-024-56044-y.